Halloran Consulting Group Announces the Creation of New Leadership Roles
Jason Milovanovic and Kim Raymer promoted to Vice Presidents
Halloran Consulting Group is pleased to announce the promotions of Jason Milovanovic to Vice President, Clinical Development and Operations and Kim Raymer to Vice President, Regulatory Affairs. These new roles are a reflection of the continued growth of Halloran’s clinical and regulatory business, the largest practices within the firm’s development business.
“Our work within life science organizations has continued to rapidly expand, and we’re very pleased to promote Kim and Jason into these new leadership roles to help us lead Halloran’s development business into the future. We’re fortunate to have a rich pipeline that includes many programs with the potential to change health outcomes through life-changing therapies. Due to our regular communications with FDA about development plans and strategies, our team has a very firm grasp on the latest trends and thinking from FDA and other health authorities,” said Katie McCarthy, Managing Director.
“I’ve had the pleasure of working with Halloran’s development leadership in the advancing of our clinical candidates,” said David Margolin, Senior Vice President of Clinical and Translational Medicine at Cerevance. “Most recently, we successfully completed our First-in-Human Dosing of a First-in-Class compound for Parkinson’s disease. Halloran brought regulatory and clinical operations leadership expertise and management to help us achieve this very important milestone.”
Halloran Consulting Group is a management consulting firm for the life science industry providing excellence in regulatory, quality, and clinical development. Halloran systematically assesses its clients’ needs to provide the right insight and organizational support needed to enable product success. Halloran is certified by the Women’s Business Enterprise National Council as a woman-owned business.